{"access":{"can_view":true,"can_edit":false,"can_remove":false,"can_add":false,"can_publish":false,"can_get_doi":false,"can_share":true,"can_move":true,"can_move_outside":true,"can_transfer":true,"can_download":true,"limited_run":false,"limited_private_links":false,"limited_blind_links":false,"is_locked":false},"authors":[{"name":"Katherine Brimblecombe","affiliation":"Department of Physiology, Anatomy and Genetics, University of Oxford, OX1 3PT, UK; Oxford Parkinson’s Disease Centre, University of Oxford, Oxford, United Kingdom; Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815","affiliation_url":null,"username":"m4xle112z115vle1","link":null,"image":{"source":"/img/avatars/002.png","placeholder":"/img/avatars/002.png","webp_source":""},"note":"","is_verified_user":true},{"name":"Stephanie J Cragg","affiliation":"Department of Physiology, Anatomy and Genetics, University of Oxford, OX1 3PT, UK; Oxford Parkinson’s Disease Centre, University of Oxford, Oxford, United Kingdom; Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815","affiliation_url":null,"username":"stephanie-cragg","link":"https://www.dpag.ox.ac.uk/team/stephanie-cragg","image":{"source":"/img/avatars/006.png","placeholder":"/img/avatars/006.png","webp_source":""},"note":"","is_verified_user":true}],"before_start":"","book_chapter":null,"can_accept_authorship":false,"can_be_copied":true,"can_claim_authorship":false,"can_manage_keywords":true,"can_remove_fork":false,"can_sign":false,"child_steps":{},"cited_protocols":[],"collection_items":[{"content_type_id":1,"data":{"id":78767,"guid":"EF5DDAD0C26E11ED82BE2FF7E52CE4B4","title":"Fast-scan cyclic voltammetry to assess dopamine release in ex vivo mouse brain slices ","fork_id":0,"version_id":0,"public":1,"is_prepublished":0,"title_html":"Fast-scan cyclic voltammetry to assess dopamine release in ex vivo mouse brain slices ","version_data":{"id":0,"code":"cq6pvzdn","version_class":0,"parent_id":null,"parent_uri":null,"is_same_owner":false,"is_parent_public":false,"has_pending_merge_request":false,"has_approved_merge_request":false,"merge_request":null},"creator":{"name":"Cláudia C. Mendes","username":"n4ple1y1w1v4yle1","affiliation":"","affiliation_url":"","link":"","is_verified_user":true,"image":{"source":"/img/avatars/002.png","webp_source":null,"placeholder":"/img/avatars/002.png","webp_placeholder":null}},"image":{"source":"https://content.protocols.io/files/muzwbtrd7.jpg","webp_source":null,"placeholder":"https://content.protocols.io/files/muzwbtrd7.jpg","webp_placeholder":null},"uri":"fast-scan-cyclic-voltammetry-to-assess-dopamine-re-cq6pvzdn","private_link":null,"blind_link":null}},{"content_type_id":1,"data":{"id":80963,"guid":"A06FAF90E29211EDAC5725D2752615D6","title":"Making CFM","fork_id":0,"version_id":0,"public":1,"is_prepublished":0,"title_html":"Making CFM","version_data":{"id":0,"code":"ctbbwiin","version_class":0,"parent_id":null,"parent_uri":null,"is_same_owner":false,"is_parent_public":false,"has_pending_merge_request":false,"has_approved_merge_request":false,"merge_request":null},"creator":{"name":"Cláudia C. Mendes","username":"n4ple1y1w1v4yle1","affiliation":"","affiliation_url":"","link":"","is_verified_user":true,"image":{"source":"/img/avatars/002.png","webp_source":null,"placeholder":"/img/avatars/002.png","webp_placeholder":null}},"image":{"source":"https://content.protocols.io/files/muz4btrd7.jpg","webp_source":null,"placeholder":"https://content.protocols.io/files/muz4btrd7.jpg","webp_placeholder":null},"uri":"making-cfm-ctbbwiin","private_link":null,"blind_link":null}},{"content_type_id":1,"data":{"id":81012,"guid":"26094260E36011EDB38BED03D589F728","title":"Western Blot","fork_id":0,"version_id":0,"public":1,"is_prepublished":0,"title_html":"Western Blot","version_data":{"id":0,"code":"ctcuwiww","version_class":0,"parent_id":null,"parent_uri":null,"is_same_owner":false,"is_parent_public":false,"has_pending_merge_request":false,"has_approved_merge_request":false,"merge_request":null},"creator":{"name":"Cláudia C. Mendes","username":"n4ple1y1w1v4yle1","affiliation":"","affiliation_url":"","link":"","is_verified_user":true,"image":{"source":"/img/avatars/002.png","webp_source":null,"placeholder":"/img/avatars/002.png","webp_placeholder":null}},"image":{"source":"https://content.protocols.io/files/muz6btrd7.jpg","webp_source":null,"placeholder":"https://content.protocols.io/files/muz6btrd7.jpg","webp_placeholder":null},"uri":"western-blot-ctcuwiww","private_link":null,"blind_link":null}},{"content_type_id":1,"data":{"id":87796,"guid":"D5116C6B6DDD4A29A06928031069C072","title":"Synthesis of 1-(3-Chlorophenethyl)-3-cyclopentylpyrimidine-2,4,6-(1H,3H,5H)-trione","fork_id":0,"version_id":0,"public":1,"is_prepublished":0,"title_html":"Synthesis of 1-(3-Chlorophenethyl)-3-cyclopentylpyrimidine-2,4,6-(1H,3H,5H)-trione","version_data":{"id":0,"code":"czyux7ww","version_class":0,"parent_id":null,"parent_uri":null,"is_same_owner":false,"is_parent_public":false,"has_pending_merge_request":false,"has_approved_merge_request":false,"merge_request":null},"creator":{"name":"sophie.oakley","username":"n4tle102v1u4ule1","affiliation":"","affiliation_url":"","link":"","is_verified_user":true,"image":{"source":"/img/avatars/005.png","webp_source":null,"placeholder":"/img/avatars/005.png","webp_placeholder":null}},"image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"uri":"synthesis-of-1-3-chlorophenethyl-3-cyclopentylpyri-czyux7ww","private_link":null,"blind_link":null}}],"created_on":1697591688,"creator":{"name":"Cláudia C. Mendes","affiliation":"","affiliation_url":null,"username":"n4ple1y1w1v4yle1","link":null,"image":{"source":"/img/avatars/002.png","placeholder":"/img/avatars/002.png","webp_source":""},"badges":[{"id":4,"name":"Gold power author!","image":{"source":"/img/badges/gold.svg","placeholder":"/img/badges/gold.svg"}},{"id":6,"name":"Science accelerator","image":{"source":"/img/badges/accelerator.svg","placeholder":"/img/badges/accelerator.svg"}}],"affiliations":[]},"cross_cloud_origin":null,"description":"{\"blocks\":[{\"key\":\"8phja\",\"text\":\"This collection contains three protocols detailing methods used in Brimblecombe, K.R. et al. (2023) Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine, co-varies with risk factors for Parkinson’s. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":100,\"length\":135}],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","disclaimer":"","document":"","documents":[],"doi":"dx.doi.org/10.17504/protocols.io.4r3l27dxxg1y/v2","doi_status":1,"ethics_statement":null,"fork_id":null,"fork_info":null,"forks":[],"funders":[{"funder_name":"Aligning Science Across Parkinson’s (ASAP)","grant_id":"Grant ID: ASAP-020370"}],"groups":[{"id":53962,"uri":"team-cragg","title":"Team Cragg","is_public":false,"image":{"source":"https://s3.amazonaws.com/protocols-files/files/90604BF3D52411ECB9A40A58A9FEAC02-placeholder.png","placeholder":"https://s3.amazonaws.com/protocols-files/files/90604BF3D52411ECB9A40A58A9FEAC02-placeholder.png"},"tech_support":{"email":null,"phone":null,"use_email":false,"hide_contact":false,"url":null}}],"guid":"BAF44E526D5311EE8A230A58A9FEAC02","guidelines":"","has_references":false,"has_step_reagents":false,"has_versions":true,"id":89477,"image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"image_attribution":"","in_trash":false,"is_bookmarked":false,"is_contact_suspended":false,"is_content_confidential":false,"is_content_warning":false,"is_doi_reserved":false,"is_in_pending_publishing":false,"is_in_transfer":false,"is_owner":true,"is_research":true,"is_retracted":false,"is_shared_directly":false,"is_subprotocol":null,"is_unlisted":false,"item_id":1176119,"journal":null,"journals":[],"keywords":"","last_modified":1697591906,"link":"","location":null,"manuscript_citation":"","materials":[],"materials_text":"","ownership_history":null,"parent_collections":[],"parent_protocols":[],"peer_reviewed":false,"protocol_references":"","public":true,"public_fork_note":"","published_on":1697591906,"references":[],"related_equipments":[],"related_materials":[],"reserved_doi":"","retraction_reason":null,"samples":{},"shared_access_id":16,"show_comparison":true,"sign_info":null,"space_access":{"can_view":false,"can_edit":false,"can_remove":false,"can_add":false,"can_publish":true,"can_get_doi":true,"can_share":false,"can_move":false,"can_move_outside":false,"can_transfer":false,"can_download":false,"limited_run":false,"limited_private_links":false,"limited_blind_links":false,"is_locked":false},"state_version_id":0,"stats":{"is_voted":false,"number_of_views":72,"number_of_steps":0,"number_of_bookmarks":0,"number_of_comments":0,"number_of_bookmarked_comments":0,"number_of_steps_comments":0,"number_of_protocol_comments":0,"number_of_exports":0,"number_of_runs":0,"number_of_votes":0,"number_of_reagents":0,"number_of_equipments":0,"number_of_collections":0,"number_of_forks":{"private":0,"public":0},"number_of_accessible_forks":0},"status":{"id":1,"info":"We use this collection and it's working"},"steps":null,"template_id":2,"title":"Brimblecombe, K.R. et al. (2023) Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine, co-varies with risk factors for Parkinson’s. ","title_html":"Brimblecombe, K.R. et al. (2023) Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine, co-varies with risk factors for Parkinson’s. ","type_id":3,"units":[{"id":1,"type_id":3,"name":"µL","can_manage":0,"read_only":0},{"id":2,"type_id":3,"name":"mL","can_manage":0,"read_only":0},{"id":3,"type_id":3,"name":"L","can_manage":0,"read_only":0},{"id":4,"type_id":3,"name":"µg","can_manage":0,"read_only":0},{"id":5,"type_id":3,"name":"mg","can_manage":0,"read_only":0},{"id":6,"type_id":3,"name":"g","can_manage":0,"read_only":0},{"id":7,"type_id":3,"name":"kg","can_manage":0,"read_only":0},{"id":8,"type_id":3,"name":"ng","can_manage":0,"read_only":0},{"id":9,"type_id":3,"name":"Hz","can_manage":0,"read_only":0},{"id":10,"type_id":24,"name":"°C","can_manage":0,"read_only":0},{"id":11,"type_id":24,"name":"°К","can_manage":0,"read_only":0},{"id":12,"type_id":24,"name":"°F","can_manage":0,"read_only":0},{"id":13,"type_id":25,"name":"Mass Percent","can_manage":0,"read_only":0},{"id":14,"type_id":25,"name":"% volume","can_manage":0,"read_only":0},{"id":15,"type_id":25,"name":"Mass / % volume","can_manage":0,"read_only":0},{"id":16,"type_id":25,"name":"Parts per Million (PPM)","can_manage":0,"read_only":0},{"id":17,"type_id":25,"name":"Parts per Billion (PPB)","can_manage":0,"read_only":0},{"id":18,"type_id":25,"name":"Parts per Trillion (PPT)","can_manage":0,"read_only":0},{"id":19,"type_id":25,"name":"Mole Fraction","can_manage":0,"read_only":0},{"id":20,"type_id":25,"name":"Mole Percent","can_manage":0,"read_only":0},{"id":21,"type_id":25,"name":"Molarity (M)","can_manage":0,"read_only":1},{"id":22,"type_id":25,"name":"Molarity (m)","can_manage":0,"read_only":0},{"id":23,"type_id":25,"name":"Genome copies per ml","can_manage":0,"read_only":0},{"id":24,"type_id":3,"name":"μV","can_manage":0,"read_only":0},{"id":25,"type_id":3,"name":"ms","can_manage":0,"read_only":0},{"id":26,"type_id":3,"name":"pg","can_manage":0,"read_only":0},{"id":27,"type_id":25,"name":"Molarity dilutions","can_manage":0,"read_only":0},{"id":28,"type_id":25,"name":"millimolar (mM)","can_manage":0,"read_only":0},{"id":29,"type_id":25,"name":"micromolar (µM)","can_manage":0,"read_only":0},{"id":30,"type_id":25,"name":"nanomolar (nM)","can_manage":0,"read_only":0},{"id":31,"type_id":25,"name":"picomolar (pM)","can_manage":0,"read_only":0},{"id":32,"type_id":24,"name":"Room temperature","can_manage":0,"read_only":0},{"id":33,"type_id":30,"name":"rpm","can_manage":0,"read_only":0},{"id":34,"type_id":30,"name":"x g","can_manage":0,"read_only":0},{"id":165,"type_id":24,"name":"On ice","can_manage":0,"read_only":0},{"id":200,"type_id":32,"name":"cm","can_manage":0,"read_only":0},{"id":201,"type_id":32,"name":"mm","can_manage":0,"read_only":0},{"id":202,"type_id":32,"name":"µm","can_manage":0,"read_only":0},{"id":203,"type_id":32,"name":"nm","can_manage":0,"read_only":0},{"id":204,"type_id":25,"name":"mg/mL","can_manage":0,"read_only":0},{"id":205,"type_id":25,"name":"µg/µL","can_manage":0,"read_only":0},{"id":206,"type_id":25,"name":"% (v/v)","can_manage":0,"read_only":0},{"id":1324,"type_id":30,"name":"rcf","can_manage":0,"read_only":0},{"id":1359,"type_id":35,"name":"Bar","can_manage":0,"read_only":0},{"id":1360,"type_id":35,"name":"Pa","can_manage":0,"read_only":0}],"uri":"brimblecombe-k-r-et-al-2023-inhibition-of-striatal-c3mdyk26","url":"https://www.protocols.io/view/brimblecombe-k-r-et-al-2023-inhibition-of-striatal-c3mdyk26","version_class":82367,"version_data":{"id":1,"code":"c3mdyk26","version_class":82367,"parent_id":82367,"parent_uri":"brimblecombe-k-r-et-al-2023-inhibition-of-striatal-cun7wvhn","is_same_owner":true,"is_parent_public":true,"has_pending_merge_request":false,"has_approved_merge_request":true,"merge_request":{"id":2218,"creator":{"name":"Cláudia C. Mendes","affiliation":null,"affiliation_url":null,"username":"n4ple1y1w1v4yle1","link":null,"image":{"source":"/img/avatars/002.png","placeholder":"/img/avatars/002.png","webp_source":""}},"created_on":1697591747,"can_manage":true}},"version_id":1,"version_uri":"brimblecombe-k-r-et-al-2023-inhibition-of-striatal-4r3l27dxxg1y/v2","versions":[{"id":82367,"title":"Brimblecombe, K.R. et al. (2023) Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine, co-varies with risk factors for Parkinson’s. ","title_html":"Brimblecombe, K.R. et al. (2023) Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine, co-varies with risk factors for Parkinson’s. ","image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"doi":"dx.doi.org/10.17504/protocols.io.4r3l27dxxg1y/v1","uri":"brimblecombe-k-r-et-al-2023-inhibition-of-striatal-cun7wvhn","published_on":1686301245,"modified_on":1686301245,"version_class":82367,"version_id":0,"version_code":"cun7wvhn","version_uri":"brimblecombe-k-r-et-al-2023-inhibition-of-striatal-4r3l27dxxg1y/v1","created_on":1684920365,"categories":null,"type_id":3,"creator":{"name":"Cláudia C. Mendes","affiliation":null,"affiliation_url":null,"username":"n4ple1y1w1v4yle1","link":null,"image":{"source":"/img/avatars/002.png","placeholder":"/img/avatars/002.png","webp_source":""}},"stats":{"number_of_comments":0,"last_comment_time":0}},{"id":88315,"title":"Brimblecombe, K.R. et al. (2023) Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine, co-varies with risk factors for Parkinson’s.","title_html":"\u003cp\u003eBrimblecombe, K.R. et al. (2023) Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine, co-varies with risk factors for Parkinson’s.\u003c/p\u003e","image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"doi":null,"uri":"brimblecombe-k-r-et-al-2023-inhibition-of-striatal-c2g3ybyn","published_on":0,"modified_on":1695654561,"version_class":82367,"version_id":1,"version_code":"c2g3ybyn","version_uri":"","created_on":1695649826,"categories":null,"type_id":3,"creator":{"name":"Cláudia C. Mendes","affiliation":null,"affiliation_url":null,"username":"n4ple1y1w1v4yle1","link":null,"image":{"source":"/img/avatars/002.png","placeholder":"/img/avatars/002.png","webp_source":""}},"stats":{"number_of_comments":0,"last_comment_time":0}},{"id":89477,"title":"Brimblecombe, K.R. et al. (2023) Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine, co-varies with risk factors for Parkinson’s. ","title_html":"Brimblecombe, K.R. et al. (2023) Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine, co-varies with risk factors for Parkinson’s. ","image":{"source":"https://www.protocols.io/img/default_protocol.png","webp_source":null,"placeholder":"https://www.protocols.io/img/default_protocol.png","webp_placeholder":null},"doi":"dx.doi.org/10.17504/protocols.io.4r3l27dxxg1y/v2","uri":"brimblecombe-k-r-et-al-2023-inhibition-of-striatal-c3mdyk26","published_on":1697591906,"modified_on":1697591906,"version_class":82367,"version_id":1,"version_code":"c3mdyk26","version_uri":"brimblecombe-k-r-et-al-2023-inhibition-of-striatal-4r3l27dxxg1y/v2","created_on":1697591688,"categories":null,"type_id":3,"creator":{"name":"Cláudia C. Mendes","affiliation":null,"affiliation_url":null,"username":"n4ple1y1w1v4yle1","link":null,"image":{"source":"/img/avatars/002.png","placeholder":"/img/avatars/002.png","webp_source":""}},"stats":{"number_of_comments":0,"last_comment_time":0}}],"warning":""}